skip to primary navigationskip to content

New important article published by CTR team in BMJ: Pre-eclampsia pathophysiology and clinical implications

last modified Jul 16, 2019 12:01 PM

Pre-eclampsia: pathophysiology and clinical implications

Important new article published by CTR team G. Burton, C. Redman, J. Roberts and A. Moffett

 Read it online at: 

https://www.bmj.com/content/366/bmj.l2381

 

Abstract (copied from the British Medical Journal)

Pre-eclampsia is a common disorder that particularly affects first pregnancies. The clinical presentation is highly variable but hypertension and proteinuria are usually seen. These systemic signs arise from soluble factors released from the placenta as a result of a response to stress of syncytiotrophoblast. There are two sub-types: early and late onset pre-eclampsia, with others almost certainly yet to be identified. Early onset pre-eclampsia arises owing to defective placentation, whilst late onset pre-eclampsia may center around interactions between normal senescence of the placenta and a maternal genetic predisposition to cardiovascular and metabolic disease. The causes, placental and maternal, vary among individuals. Recent research has focused on placental-uterine interactions in early pregnancy. The aim now is to translate these findings into new ways to predict, prevent, and treat pre-eclampsia.